Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent.

Merchant M, Ma X, Maun HR, Zheng Z, Peng J, Romero M, Huang A, Yang NY, Nishimura M, Greve J, Santell L, Zhang YW, Su Y, Kaufman DW, Billeci KL, Mai E, Moffat B, Lim A, Duenas ET, Phillips HS, Xiang H, Young JC, Vande Woude GF, Dennis MS, Reilly DE, Schwall RH, Starovasnik MA, Lazarus RA, Yansura DG.

Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):E2987-96. doi: 10.1073/pnas.1302725110. Epub 2013 Jul 23.

2.

Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate.

Lewis Phillips GD, Li G, Dugger DL, Crocker LM, Parsons KL, Mai E, Blättler WA, Lambert JM, Chari RV, Lutz RJ, Wong WL, Jacobson FS, Koeppen H, Schwall RH, Kenkare-Mitra SR, Spencer SD, Sliwkowski MX.

Cancer Res. 2008 Nov 15;68(22):9280-90. doi: 10.1158/0008-5472.CAN-08-1776.

3.

Quantification of viable tumor microvascular characteristics by multispectral analysis.

Berry LR, Barck KH, Go MA, Ross J, Wu X, Williams SP, Gogineni A, Cole MJ, Van Bruggen N, Fuh G, Peale F, Ferrara N, Ross S, Schwall RH, Carano RA.

Magn Reson Med. 2008 Jul;60(1):64-72. doi: 10.1002/mrm.21470.

4.

Quantification of tumor tissue populations by multispectral analysis.

Carano RA, Ross AL, Ross J, Williams SP, Koeppen H, Schwall RH, Van Bruggen N.

Magn Reson Med. 2004 Mar;51(3):542-51.

5.

Synergistic induction of tumor antigens by Wnt-1 signaling and retinoic acid revealed by gene expression profiling.

Tice DA, Szeto W, Soloviev I, Rubinfeld B, Fong SE, Dugger DL, Winer J, Williams PM, Wieand D, Smith V, Schwall RH, Pennica D, Polakis P.

J Biol Chem. 2002 Apr 19;277(16):14329-35. Epub 2002 Feb 6.

6.

Overexpression of the retinoic acid-responsive gene Stra6 in human cancers and its synergistic induction by Wnt-1 and retinoic acid.

Szeto W, Jiang W, Tice DA, Rubinfeld B, Hollingshead PG, Fong SE, Dugger DL, Pham T, Yansura DG, Wong TA, Grimaldi JC, Corpuz RT, Singh JS, Frantz GD, Devaux B, Crowley CW, Schwall RH, Eberhard DA, Rastelli L, Polakis P, Pennica D.

Cancer Res. 2001 May 15;61(10):4197-205.

7.

Hepatocyte growth factor receptor in acute tubular necrosis.

Rabkin R, Fervenza F, Tsao T, Sibley R, Friedlaender M, Hsu F, Lassman C, Hausmann M, Huie P, Schwall RH.

J Am Soc Nephrol. 2001 Mar;12(3):531-40.

8.

Hepatocyte growth factor and vitamin D cooperatively inhibit androgen-unresponsive prostate cancer cell lines.

Qadan LR, Perez-Stable CM, Schwall RH, Burnstein KL, Ostenson RC, Howard GA, Roos BA.

Endocrinology. 2000 Jul;141(7):2567-73.

PMID:
10875259
9.

Safety and antitumor activity of recombinant soluble Apo2 ligand.

Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, DeForge L, Koumenis IL, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z, Schwall RH.

J Clin Invest. 1999 Jul;104(2):155-62.

10.

Retrovirus-mediated in vivo gene transfer in the replicating liver using recombinant hepatocyte growth factor without liver injury or partial hepatectomy.

Kosai KI, Finegold MJ, Thi-Huynh BT, Tewson M, Ou CN, Bowles N, Woo SL, Schwall RH, Darlington GJ.

Hum Gene Ther. 1998 Jun 10;9(9):1293-301.

PMID:
9650614
11.

Paracrine effects of hepatocyte growth factor/scatter factor on non-small-cell lung carcinoma cell lines.

Yi S, Chen JR, Viallet J, Schwall RH, Nakamura T, Tsao MS.

Br J Cancer. 1998 Jun;77(12):2162-70.

12.

Vascular endothelial growth factor is essential for corpus luteum angiogenesis.

Ferrara N, Chen H, Davis-Smyth T, Gerber HP, Nguyen TN, Peers D, Chisholm V, Hillan KJ, Schwall RH.

Nat Med. 1998 Mar;4(3):336-40.

PMID:
9500609
13.

Heparin induces dimerization and confers proliferative activity onto the hepatocyte growth factor antagonists NK1 and NK2.

Schwall RH, Chang LY, Godowski PJ, Kahn DW, Hillan KJ, Bauer KD, Zioncheck TF.

J Cell Biol. 1996 May;133(3):709-18.

14.

Sulfated oligosaccharides promote hepatocyte growth factor association and govern its mitogenic activity.

Zioncheck TF, Richardson L, Liu J, Chang L, King KL, Bennett GL, Fügedi P, Chamow SM, Schwall RH, Stack RJ.

J Biol Chem. 1995 Jul 14;270(28):16871-8.

15.

Induction of liver growth in normal mice by infusion of hepatocyte growth factor/scatter factor.

Roos F, Ryan AM, Chamow SM, Bennett GL, Schwall RH.

Am J Physiol. 1995 Feb;268(2 Pt 1):G380-6.

PMID:
7864135
16.

Induction of apoptosis in the murine liver with recombinant human activin A.

Hully JR, Chang L, Schwall RH, Widmer HR, Terrell TG, Gillett NA.

Hepatology. 1994 Oct;20(4 Pt 1):854-62.

PMID:
7927226
17.

Activin induces cell death in hepatocytes in vivo and in vitro.

Schwall RH, Robbins K, Jardieu P, Chang L, Lai C, Terrell TG.

Hepatology. 1993 Aug;18(2):347-56.

PMID:
8340063
18.

Hypothalamic infusion of activin A increases water consumption and urine volume in the rat.

Schwall RH, Jakeman LB, Altar CA.

Neuroendocrinology. 1993 Mar;57(3):510-6.

PMID:
8321420
19.

Reduction of alpha-naphthylisothiocyanate-induced hepatotoxicity by recombinant human hepatocyte growth factor.

Roos F, Terrell TG, Godowski PJ, Chamow SM, Schwall RH.

Endocrinology. 1992 Dec;131(6):2540-4.

PMID:
1446596
20.

In vivo regulation of FSH synthesis by inhibin and activin.

Carroll RS, Kowash PM, Lofgren JA, Schwall RH, Chin WW.

Endocrinology. 1991 Dec;129(6):3299-304.

PMID:
1954905
21.

Effect of recombinant activin on androgen synthesis in cultured human thecal cells.

Hillier SG, Yong EL, Illingworth PJ, Baird DT, Schwall RH, Mason AJ.

J Clin Endocrinol Metab. 1991 Jun;72(6):1206-11.

PMID:
2026742
22.

The effects of activin on follicle-stimulating hormone secretion and biosynthesis in human glycoprotein hormone-producing pituitary adenomas.

Alexander JM, Jameson JL, Bikkal HA, Schwall RH, Klibanski A.

J Clin Endocrinol Metab. 1991 Jun;72(6):1261-7.

PMID:
1902844
23.
24.

Evidence for an autocrine role of activin B within rat anterior pituitary cultures.

Corrigan AZ, Bilezikjian LM, Carroll RS, Bald LN, Schmelzer CH, Fendly BM, Mason AJ, Chin WW, Schwall RH, Vale W.

Endocrinology. 1991 Mar;128(3):1682-4.

PMID:
1900235
25.

Effect of recombinant inhibin on androgen synthesis in cultured human thecal cells.

Hillier SG, Yong EL, Illingworth PJ, Baird DT, Schwall RH, Mason AJ.

Mol Cell Endocrinol. 1991 Feb;75(2):R1-6. Erratum in: Mol Cell Endocrinol 1991 Aug;79(1-3):177.

PMID:
2050269
26.

In vivo comparison of the follicle-stimulating hormone-suppressing activity of follistatin and inhibin in ovariectomized rats.

DePaolo LV, Shimonaka M, Schwall RH, Ling N.

Endocrinology. 1991 Feb;128(2):668-74.

PMID:
1899217
27.

Erythroid differentiation bioassays for activin.

Schwall RH, Lai C.

Methods Enzymol. 1991;198:340-6. No abstract available.

PMID:
1857227
28.

Purification and characterization of recombinant human activin B.

Schmelzer CH, Burton LE, Tamony CM, Schwall RH, Mason AJ, Liegeois N.

Biochim Biophys Acta. 1990 Jun 19;1039(2):135-41.

PMID:
2364091
29.

Localization of inhibin/activin subunit mRNAs within the primate ovary.

Schwall RH, Mason AJ, Wilcox JN, Bassett SG, Zeleznik AJ.

Mol Endocrinol. 1990 Jan;4(1):75-9.

PMID:
2325670
30.

Activin B: precursor sequences, genomic structure and in vitro activities.

Mason AJ, Berkemeier LM, Schmelzer CH, Schwall RH.

Mol Endocrinol. 1989 Sep;3(9):1352-8.

PMID:
2575216
31.

Recombinant expression and characterization of human activin A.

Schwall RH, Nikolics K, Szonyi E, Gorman C, Mason AJ.

Mol Endocrinol. 1988 Dec;2(12):1237-42.

PMID:
3216863
32.

Selective and indirect modulation of human multipotential and erythroid hematopoietic progenitor cell proliferation by recombinant human activin and inhibin.

Broxmeyer HE, Lu L, Cooper S, Schwall RH, Mason AJ, Nikolics K.

Proc Natl Acad Sci U S A. 1988 Dec;85(23):9052-6.

33.

Activin stimulates secretion of follicle-stimulating hormone from pituitary cells desensitized to gonadotropin-releasing hormone.

Schwall RH, Szonyi E, Mason AJ, Nikolics K.

Biochem Biophys Res Commun. 1988 Mar 30;151(3):1099-104.

PMID:
3128289
34.

Changes in the distribution of sizes of ovine luteal cells during the estrous cycle.

Schwall RH, Gamboni F, Mayan MH, Niswender GD.

Biol Reprod. 1986 Jun;34(5):911-8.

PMID:
3460642
35.

Differential regulation by LH and prostaglandins of steroidogenesis in small and large luteal cells of the ewe.

Schwall RH, Sawyer HR, Niswender GD.

J Reprod Fertil. 1986 Mar;76(2):821-9. Review. No abstract available.

PMID:
3009800
36.

Regulation of luteal function in domestic ruminants: new concepts.

Niswender GD, Schwall RH, Fitz TA, Farin CE, Sawyer HR.

Recent Prog Horm Res. 1985;41:101-51. Review. No abstract available.

PMID:
2996087
37.

Inhibition of synthesis of luteinizing hormone (LH) receptors by a down-regulating dose of LH.

Schwall RH, Erickson GF.

Endocrinology. 1984 Apr;114(4):1114-23.

PMID:
6323131
38.
39.

Supplemental Content

Loading ...
Support Center